{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "HHS & DOJ FY 2022 Enforcement Targeted Fraud in COVID-19, Telemedicine, Opioid and Prescription Drugs, and Substance Use Treatment Centers, Among Other Initiatives",
    "url": "https://www.lexblog.com/2023/12/01/hhs-doj-fy-2022-enforcement-targeted-fraud-in-covid-19-telemedicine-opioid-and-prescription-drugs-and-substance-use-treatment-centers-among-other-initiatives/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-PRPEFTMS",
        "url": "https://www.lexblog.com/lib/PRPEFTMS/"
    },
    "datePublished": "2023-12-01T16:21:01-05:00",
    "dateModified": "2023-12-01T13:22:13-05:00",
    "author": {
        "@type": "Person",
        "name": "Amy Dilcher, Elizabeth Nevins, Megan Miller"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Sheppard, Mullin, Richter & Hampton LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Healthcare Law Blog",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "https://www.sheppardhealthlaw.com/?p=6051",
    "sourceStability": "may-move"
}